Skip to main content
. 2022 Nov 21;10(1):e200056. doi: 10.1212/NXI.0000000000200056

Figure 1. Study Population.

Figure 1

Inclusion criteria flowchart. ASC = Academic Specialist Center; DMT = disease-modifying therapy, RRMS = relapsing-remitting MS; RTX = rituximab; SMSReg = Swedish MS Registry.